e-learning
resources
Stockholm 2007
Monday 17.09.2007
Pharmacological treatment of mild to moderate persistent asthma: new approaches
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment of moderate persistent asthma: new options
E. D. Bateman (Cape Town, South Africa)
Source:
Annual Congress 2007 - Pharmacological treatment of mild to moderate persistent asthma: new approaches
Session:
Pharmacological treatment of mild to moderate persistent asthma: new approaches
Session type:
Hot topics
Number:
1929
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. D. Bateman (Cape Town, South Africa). Treatment of moderate persistent asthma: new options. Annual Congress 2007 - Pharmacological treatment of mild to moderate persistent asthma: new approaches
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Filling the gaps: future treatment options for mild asthma
Source: International Congress 2018 – The complexities of managing mild asthma
Year: 2018
Severe asthma: classification and treatment
Source: Virtual Congress 2021 – Clinical year in review
Year: 2021
Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment?
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Bronchial thermoplasty: a new therapeutic option for the treatment of severe, uncontrolled asthma in adults
Source: Eur Respir Rev 2014; 23: 510-518
Year: 2014
Severe asthma: approach to diagnosis and treatment
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008
The challenge of treating uncontrolled asthma on Step 3 and higher: Comparing options
Source: International Congress 2015 – The challenge of treating uncontrolled asthma on Step 3 and higher: Comparing options
Year: 2015
Are current treatment protocols adequate for children with mild intermittent asthma?
Source: Eur Respir J 2005; 26: Suppl. 49, 397s
Year: 2005
Management of difficult-to-treat severe asthma
Source: Eur Respir Mon 2011; 51: 282-296
Year: 2011
The management of mild asthma
Source: Eur Respir J, 57 (4) 2003051; 10.1183/13993003.03051-2020
Year: 2021
Acute severe asthma: evidence-based management of asthma exacerbations
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008
Refining asthma treatment for mild asthma
Source: Virtual Congress 2020 – Rethinking asthma
Year: 2020
Treatment of severe childhood asthma: what’s the evidence?
Source: Annual Congress 2005 - Difficult asthma in children
Year: 2005
L-carnitine improves the asthma control in children with moderate persistent asthma
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017
Chronic cough: Are we integrating non-pharmacological therapies into treatment plans?
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017
Pharmacological strategies for self-management of asthma exacerbations
Source: Eur Respir J 2006; 28: 182-199
Year: 2006
Managing severe asthma: do we need to do more?
Source: Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept